Read + Share
Shore ND, Powles TB, Bedke J, Galsky MD, et al. Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer:
the randomized phase 3 CREST trial. Nat Med 2025 May 31. doi: 10.1038/s41591-025-03738.
PMID: 40450141
|
 |
|
Shore ND, Powles TB, Bedke J, Galsky MD, et al. Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer:
the randomized phase 3 CREST trial. Nat Med 2025 May 31. doi: 10.1038/s41591-025-03738.
PMID: 40450141
|
|
|
|